HNN3.0

Project cooperationUpdated on 22 January 2026

Regulatory Science Partner

Director Future Medicines Institute at Queen's University Belfast

BELFAST, United Kingdom

About

In my current role as Director of the Future Medicines Institute I have established a Regulatory Science function to enable the development of new drugs and devices utilising novel modalities. We have significant dry lab capabilities and are driven to integrate bioinformatic and AI approaches into drug and device development. Our Regulatory Science function is focused on utilising the extensive wet lab capabilities within the Institute to support the development of NAMs. We believe our capabilities combined with our expertise in Regulatory Science would be an asset to a Consortium.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
  • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

Type

  • Partner seeks Consortium/Coordinator

Organisation

Queen's University Belfast

University

Belfast, United Kingdom

Similar opportunities